Sulfisoxazole

  • TRADE NAMES: Gantrisin (Roche); Isoxazine; Novo-Soxazole; Oxazole; Pediazole; Sulfazin; Sulfazole; Sulizole; Thiazin; Urazole
  • INDICATIONS: Various infections caused by susceptible organisms
  • CLASS: Antibiotic; sulfonamide
  • HALF-LIFE: 3–7 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Anticoagulants, Cyclosporine, Methotrexate, Warfarin

PREGNANCY CATEGORY: C

Sulfisoxazole is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.

Our database has 34 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
GENITOURINARY.
HEMATOLOGIC.
OTHER.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top